Inverness Counsel LLC Gilead Sciences, Inc. Transaction History

Inverness Counsel LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$64.88 - $73.64 $196,910 - $223,497	-3,035 Closed	0 $0
Q3 2021 Nov 02, 2021	BUY	$67.69 - $73.03 $205,439 - $221,646	3,035 New	3,035 $212,000
Q3 2020 Nov 03, 2020	SELL	$62.1 - $78.08 $168,663 - $212,065	-2,716 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$72.34 - $84.0 $196,475 - $228,144	2,716 New	2,716 $209,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Inverness Counsel LLC , based on Form 13F filings with the SEC.

Stay updated on Inverness Counsel LLC with notifications on news.